Stereotaxis (STXS) Announces First Robotic MAGiC Sweep Catheter Procedure at Deborah Heart and Lung Center

Stereotaxis, Inc. (NYSE:STXS) is one of the 15 Best Robotics Stocks to Buy Under $20.

On September 2, 2025, Stereotaxis, Inc. (NYSE:STXS) announced that the Deborah Heart and Lung Center in New Jersey had successfully completed the first robotic high-density mapping procedure in the U.S. with its MAGiC Sweep™ catheter. This catheter, the first and only robotically steered high-density electrophysiology mapping catheter, provides more precise and comprehensive maps of cardiac architecture for improved arrhythmia diagnosis and treatment. The rollout follows recent FDA clearance, with a European regulatory review also underway.

Stereotaxis, Inc. (NYSE:STXS) is a global leader in surgical robotics for minimally invasive endovascular procedures. Its robotic systems, tools, and information platforms enable safer, more accurate treatments. Over 150,000 patients worldwide have benefited from its technology. It is one of the best robotic stocks.

While we acknowledge the potential of STXS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Stocks That Will Benefit From AI and 12 Best Quantum Computing Stocks to Buy According to Wall Street Analysts.

Disclosure: None.